Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report
暂无分享,去创建一个
T. Yamazaki | A. Shimizu | Y. Wada | K. Takeuchi | T. Sano | Y. Takeuchi | T. Abe | K. Tominaga | N. Kuwahara | Emi Sakamoto | Haruka Takahashi | Syun Sakurabayashi
[1] Mengyao Sun,et al. Clinical and pathological features of anti-glomerular basement membrane disease associated with membranous nephropathy: an observational study , 2022, Renal failure.
[2] Liyi Xie,et al. Analysis of the Expression of Exostosins and Clinicopathological Features in Membranous Lupus Nephritis in a Chinese Cohort , 2022, Kidney international reports.
[3] Y. Wada,et al. Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis , 2021, Virchows Archiv.
[4] J. Grande,et al. In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes. , 2021, Journal of the American Society of Nephrology : JASN.
[5] T. Makino,et al. A Case of Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis Overlap Syndrome , 2021, Case reports in rheumatology.
[6] S. Sethi. New 'Antigens' in Membranous Nephropathy. , 2020, Journal of the American Society of Nephrology : JASN.
[7] D. Gladman,et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus , 2019, Arthritis & rheumatology.
[8] U. Specks,et al. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy. , 2019, Journal of the American Society of Nephrology : JASN.
[9] K. Nakanishi,et al. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A2 receptor in membranous nephropathy-lesions: report of two patients with microscopic polyangiitis , 2018, BMC Nephrology.
[10] C. Pusey,et al. Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy , 2017, Kidney international.
[11] C. Zeng,et al. Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case–control study , 2017, BMJ Open.
[12] C. Alpers,et al. AJKD Atlas of Renal Pathology: Pauci-immune Necrotizing Crescentic Glomerulonephritis. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] C. Alpers,et al. AJKD Atlas of Renal Pathology: Anti-Glomerular Basement Membrane Antibody-Mediated Glomerulonephritis. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] E. Andrès,et al. Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis , 2016, Medicine.
[15] Xander M R van Wijk,et al. Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis. , 2014, Kidney international.
[16] C. Terao,et al. A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex , 2014, Lupus.
[17] Z. Amoura,et al. Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome? , 2012, Rheumatology International.
[18] Ming-hui Zhao,et al. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity. , 2009, Human immunology.
[19] P. van Paassen,et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] T. Dougan,et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. , 2004, Kidney international.
[21] L. Chiche,et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] M. García-Carrasco,et al. Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly , 2003, Lupus.
[23] S. Luo,et al. The clinical features and prognosis of lupus with disease onset at age 65 and older , 2000, Lupus.
[24] A. Collins,et al. Comparison of anti-GBM antibodies in sera with or without ANCA. , 1997, Journal of the American Society of Nephrology : JASN.
[25] D. Jayne,et al. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. , 1990, Kidney international.